Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Acquire Molecular Labeling Firms Quantum Dot and BioPixels

NEW YORK, Oct. 6 (GenomeWeb News) - Invitrogen will acquire Quantum Dot and the BioPixels business unit of BioCrystal, both molecular probe providers, the company said today. In addition, Invitrogen said it has has struck a deal with Georgia Tech Research to exclusively license nanocluster technology.

 

"These acquisitions, when combined with the license from Georgia Tech, provide Invitrogen with a significant intellectual property position and robust platform for product development based on advanced inorganic materials science for molecular detection," said Invitrogen's general manager of molecular probes, Augie Sick, in a company statement.

 

Invitrogen did not disclose the terms of the two acquisitions and the license agreement.

 

Quantum Dot offers biomolecular labeling and detection using its Quantum Dot semi-conductur nanocrystals, which emit bright light in a range of colors. BioPixels provides coatings and metal alloys for semi-conductor nanocrystals. Combining the two technologies will allow the creation of improved particles, according to Invitrogen.

 

The agreement with Georgia Tech gives the company access to nanoclusters that permit "true single molecule detection and representing another rapproach to the next generation of high sensitivity labeling and detection applications."

 

Further, Invitrogen said it has closed its acquisition of Biosource International. In July, the company announced its plan to purchase Biosource, a provider of proteins, antibodies, and other reagents, for $130 million in cash.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.